Cosmeceutical adjuvant in the prophylaxis and treatment of folliculitis caused by the activity of EGF-R inhibitory drugs.
This new class of drugs has become available relatively recently in cancer therapy and has made it necessary to focus attention on the management of skin reactions that may arise during their use. The most significant events occur at the level of the pilo-sebaceous follicle with the appearance of folliculitis and structural changes in the hair. The presence of A Salicylic acid 2% with pickling activity and Z colloidal olfo 2% with sebum-regulating activity contrast the onset of follicolytic rush and rapidly attenuate its entity if already present.
There are no reviews yet.